Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L; HERALD Study Group. Kremsner PG, et al. Among authors: lehmann c. Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826381 Free PMC article. Clinical Trial.
Results of the Cologne Corona Surveillance (CoCoS) study - a cross-sectional study: survey data on risk factors of SARS-CoV-2 infection in adults.
Oberste M, Schnörch N, Shah-Hosseini K, Asenova T, Dewald F, Lehmann C, Buess M, Fätkenheuer G, Klein F, Rosenberger KD, Kossow A, Neuhann F, Hellmich M. Oberste M, et al. Among authors: lehmann c. BMC Public Health. 2023 Feb 6;23(1):260. doi: 10.1186/s12889-023-15047-6. BMC Public Health. 2023. PMID: 36747171 Free PMC article.
A Short History of B-Cell HLA Epitopes.
Doxiadis I, Loeffler-Wirth H, Lachmann N, Lehmann C. Doxiadis I, et al. Among authors: lehmann c. Transfus Med Hemother. 2024 Apr 22;51(3):152-157. doi: 10.1159/000538447. eCollection 2024 Jun. Transfus Med Hemother. 2024. PMID: 38867808 Free PMC article. Review.
Better Guidelines and Policies: AAP's Partnership for Policy Implementation.
Lehmann CU, Adams WG, Chaparro JD, Fiks AG, Grout RW, Leu MG, Mendonca EA, Michel JJ, Okechukwu K, Salmon J, Sharifi M, Downs SM. Lehmann CU, et al. Pediatrics. 2024 Jun 12:e2023061360. doi: 10.1542/peds.2023-061360. Online ahead of print. Pediatrics. 2024. PMID: 38864111
Generalized cue reactivity in dopamine neurons after opioids.
Lehmann CM, Miller NE, Nair VS, Costa KM, Schoenbaum G, Moussawi K. Lehmann CM, et al. bioRxiv [Preprint]. 2024 Jun 2:2024.06.02.597025. doi: 10.1101/2024.06.02.597025. bioRxiv. 2024. PMID: 38853878 Free PMC article. Preprint.
Socioeconomic Disparities and the Prevalence of Antimicrobial Resistance.
Cooper LN, Beauchamp AM, Ingle TA, Diaz MI, Wakene AD, Katterpalli C, Keller T, Walker C, Blumberg S, Kanjilal S, Chen JH, Radunsky AP, Most ZM, Hanna JJ, Perl TM, Lehmann CU, Medford RJ. Cooper LN, et al. Among authors: lehmann cu. Clin Infect Dis. 2024 Jun 7:ciae313. doi: 10.1093/cid/ciae313. Online ahead of print. Clin Infect Dis. 2024. PMID: 38845562
Considerations for Alternative Decision-Making When Transitioning to Adulthood for Youth With Intellectual and Developmental Disabilities: Policy Statement.
Turchi RM, Kuo DZ, Rusher JW, Seltzer RR, Lehmann CU, Grout RW; COUNCIL ON CHILDREN WITH DISABILITIES; COMMITTEE ON MEDICAL LIABILITY AND RISK MANAGEMENT. Turchi RM, et al. Among authors: lehmann cu. Pediatrics. 2024 Jun 1;153(6):e2024066841. doi: 10.1542/peds.2024-066841. Pediatrics. 2024. PMID: 38804066
1,267 results